Long term survivors of AIDS asked the present generation not to be under the wrong impression that the disease is manageable and can be easily cured.
They said that the anti retroviral (ARV) therapies have kept them alive but have suffered some of the worst side effects of the ARVs. The drugs prescribed for the treatment of AIDS usually consists of a combination off ARVs. All these drugs have different toxicity levels and vary depending on the disease and the individual's immune status. The side effects of the drugs are as deadly as the disease. Kidney stones, a heart attack, depression, loss of bowel control and organ failure are some of the common but fatal side effects that an AIDS patient undergoing treatment suffers.
Number of People Affected by AIDS/HIV
Encyclopedia section of medindia explains in brief about the number of people having HIV/AIDS
Advertisement
John Sauriol a long-term survivor said that most of them are working to keep themselves fit and healthy. The side effects are so debilitating that patients who undergo treatment do not have the same quality of life as that of their peers. Though the number of patients infected with AIDS continues to survive for a longer duration their quality of life is greatly reduced.
Why immune system cant destroy HIV
Encyclopedia section of medindia explains in brief why immune system can't destroy HIV
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest AIDS/HIV News
The 35th World AIDS Day (WAD) marks an opportunity to review strides in HIV prevention, control, and management, acknowledging achievements.
World AIDS Day 2023 focuses on the theme 'Let Communities Lead,' emphasizing the power of the communities most affected by HIV in bringing an end to AIDS.
Young men involved in sexual activity with other guys are less aware and stigmatized to access PrEP, an HIV prevention drug.
Though monkeypox can affect anyone, CDC research states that approximately 40% of people diagnosed with monkeypox in the US also test positive for HIV.
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.